REGULATORY
6 Nov 2025
FDA’s hold on Intellia’s MAGNITUDE trials marks a sharper focus on CRISPR safety and long-term risk tracking
15 Jan 2026
INNOVATION
9 Jan 2026
PARTNERSHIPS
13 Jan 2026
16 Dec 2025
12 Dec 2025
New trial results suggest gene editing could move from rare use to everyday medicine, pending regulators
INSIGHTS
15 May 2025
Mammoth’s one-dose CRISPR delivery to muscle raises hopes for wider, safer genetic treatments.
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.